Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.50
Bid: 17.00
Ask: 20.00
Change: 0.00 (0.00%)
Spread: 3.00 (17.647%)
Open: 18.50
High: 18.50
Low: 18.50
Prev. Close: 18.50
STCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Market update for the quarter ended 31 March 2023

13 Apr 2023 08:00

RNS Number : 0914W
Steppe Cement Limited
13 April 2023
 

13 April 2023

Steppe Cement Ltd

Market update for the quarter ended 31 March 2023

 

In the first quarter of 2023, Steppe Cement Ltd ("Steppe Cement" or the "Company") sold 214,832

tonnes of cement for 4,938 million Tenge, compared to 281,968 tonnes of cement for 6,299 million

Tenge in the first quarter of 2022, representing a decrease of 24% and 22% respectively.

The Kazakh cement market decreased by 13% in Q1 2023 over the corresponding quarter last year.

Steppe Cement's market share decreased to 12.7% in the first quarter of 2023 from 13.7% in the first

quarter of 2022. The decrease in shipments was against a backdrop of increased interest rates and logistical issues arising from an overloading of the rail network and the priority given to the transportation of coal for heating and power.

The average price for delivered cement in Q1 was 22,985 Tenge per tonne (ex-VAT) compared with

22,341 Tenge per tonne in 2022, an increase of 3%. The ex-factory price for the current quarter stood at

19,249 Tenge per tonne, compared to 19,006 Tenge per tonne in 2022, which represented a 1% increase.

Cement exports from Kazakhstan decreased by 20% from 2022, primarily due to reduced exports to Uzbekistan, while imports to Kazakhstan decreased from 7.1% to 4.1% of the market, mostly from Russia. 

The Company currently estimates Kazakhstan's cement market demand will reduce to 10 to 10.5 million

tonnes per annum, but there is a high degree of uncertainty regarding this due to the geopolitical situation.

There are no foreign exchange restrictions on the Kazakh banking operations and the Company remains able to pay interest and dividends abroad.

 

Steppe Cement's AIM nominated adviser and broker is RFC Ambrian Limited.

Nominated Adviser: Contact Stephen Allen or Andrew Thomson at +61 8 9480 2500.

Broker: Contact Charlie Cryer at +44 20 3440 6800

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGXGDSGBBDGXX
Date   Source Headline
1st Oct 20207:00 amRNSAppointment of Alternate Directors
21st Sep 20207:00 amRNSHolding(s) in Company
16th Sep 20207:00 amRNSInterim Results and General Market Update
2nd Sep 20207:00 amRNSPurchase of Shares by Substantial Shareholder
9th Jul 20207:00 amRNSFY2019 Dividend Dates
9th Jul 20207:00 amRNSMarket Update for the First Half of 2020
9th Jul 20207:00 amRNSAGM Results
10th Jun 20207:00 amRNSNotice of AGM
10th Jun 20207:00 amRNSFinal Results and Accounts 2019
14th Apr 20207:00 amRNS1st Quarter Results
10th Jan 20208:19 amRNSPreliminary Results
7th Oct 20197:00 amRNSMarket Update for the 3rd Quarter
12th Sep 20197:00 amRNSInterim Results and General Market Update
23rd Jul 20197:00 amRNSHolding(s) in Company
10th Jul 20197:00 amRNSMarket Update for the First Half of 2019
20th Jun 20199:41 amRNSHolding(s) in Company
13th Jun 20197:00 amRNSFinal Dividend FY2018
13th Jun 20197:00 amRNSAGM Results
15th May 20197:00 amRNSAnnual Report 2018 and Notice of AGM
15th May 20197:00 amRNSCEO Statement 2018
23rd Apr 20197:00 amRNSHoldings in Company
10th Apr 20197:00 amRNSMarket update for the quarter ended 31 March 2019
4th Mar 20194:35 pmRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSHoldings in Company
10th Jan 20197:00 amRNSPreliminary Update for Year ended 31 December 2018
23rd Oct 20187:00 amRNSChange in Substantial Shareholders' Interests
8th Oct 20187:21 amRNSMarket Update for 3Q ended 30 September 2018
18th Sep 20187:00 amRNSInterim Results
13th Jul 20187:00 amRNSHolding(s) in Company
11th Jul 20187:00 amRNSMarket update for first half of 2018
25th Jun 20187:00 amRNSHolding(s) in Company
19th Jun 20187:00 amRNSDividend Announcement
15th Jun 20187:00 amRNSAGM Results
29th May 20187:00 amRNSAnnual Report 2017 and Notice of AGM
29th May 20187:00 amRNSResults and Annual Report 2017
12th Apr 20187:00 amRNSMarket update for the quarter ended 31 March 2018
15th Jan 20187:00 amRNSPreliminary Update for Year Ended 31 December 2017
8th Dec 20177:00 amRNSNew Significant Shareholder
17th Nov 20177:00 amRNSRepayment of Bonds
12th Oct 20177:00 amRNSAppointment of Independent Non-Executive Director
11th Oct 20177:00 amRNSMarket update for 3Q ended 30 September 2017
13th Sep 20177:00 amRNSInterim Results
15th Jun 20177:00 amRNSAGM Results
23rd May 20177:00 amRNSAnnual Report 2016
22nd May 20177:00 amRNSResults and Annual Report for 2016
13th Apr 20177:00 amRNSMarket update for March quarter
13th Jan 20177:00 amRNSPreliminary Update for Year Ended 31 December 2016
20th Dec 20167:00 amRNSHoldings in Company
29th Nov 20168:33 amRNSRefinancing and extension of loans
15th Nov 20167:00 amRNSPurchase of Shares by Substantial Shareholder

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.